Fortrea FSP model helps manage clinical operations and clinical trials with greater efficiency and flexibility through tailored functional service solutions.
FDA's plan to Phase Out Animal testing: Implications for Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) announced its intention to phase out animal testing requirements for monoclonal antibodies and other pharmaceuticals . While this milestone signals progress toward more ethical and innovative drug development approaches, its implications warrant careful examination.
